What is HESG's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HESG?

P/E (TTM) is n/a and 52-week range is $0.00 to $0.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HESG figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HESG?

The company profile lists revenue (TTM) near $41M, net income (TTM) near -$251.13B, EPS (TTM) near -$0.18 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Health Sciences Group Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Los Angeles, California, US, 18.71B shares outstanding, ISIN US42223A1007 when available from company profile and filing metadata.

Health Sciences Group Inc

$HESG

Consumer Staples · Consumer Staples Distribution & Retail

Run Scenarios

Browse other companiesFree AI scores and summaries for more stocks

Health Sciences Group Inc

$HESG

Consumer Staples · Consumer Staples Distribution & Retail

Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Health Sciences Group, Inc. engages in the development of healthcare mobile applications. The company is headquartered in Los Angeles, California. The company went IPO on 2001-08-03. The firm has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The firm will launch its new product, Sequesterol Advance Cardio Formula in April 2006.

IPO

2001-08-03

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

OTC MARKETS

ISIN

US42223A1007

Headquarters

Los Angeles, California, US

Shares outstanding

18.71B

NAICS sector

Manufacturing

Browse other companiesFree AI scores and summaries for more stocks

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Health Sciences Group, Inc. engages in the development of healthcare mobile applications. The company is headquartered in Los Angeles, California. The company went IPO on 2001-08-03. The firm has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The firm will launch its new product, Sequesterol Advance Cardio Formula in April 2006.

IPO

2001-08-03

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)